Tuesday, June 26, 2018 5:48:04 PM
It is the purported Chimeric Super Antigen Receptor T cell cocktail therapy promulgated by Professor Fengping Shan. Has anyone heard of any progress made on this over last two years?
One thing to be listed with the types of corporations in the report-but another to be able to credibly demonstrate some interesting potential therapy results. Are there any? If there are, why has this not been reported, This is as the report title states "..The Most Hot Topic Discussed Among Oncologists Throughout The Globe."
Do you want the stock value to be increased? What has been happening? Any presentations at scientific meetings? Any publications of any nature covering this purported CAR-T cocktail therapy? Must be-IMUN is in the report.
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM